FIELD: medicine.
SUBSTANCE: present invention relates to use of a clathrate complex of 3-(2-phenylethyl)-2-thioxo-1,3 thiazolidin-4-one β-cyclodextrin to normalize metabolism and/or increase non-specific resistance and/or growth and development of animals.
EFFECT: present invention provides the development of an agent which exhibits a corrective normalizing effect on metabolism, the physiological state of animals; improves non-specific resistance of animal organism; increases the rate of growth and development of animals; retains stability during storage and, therefore, has improved physical and chemical properties.
1 cl, 7 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
| USE OF CLATHRATE COMPLEX OF 20-HYDROXYECDYSONE WITH ARABINOGALACTAN FOR NORMALIZATION OF METABOLISM, INCREASE IN NON-SPECIFIC RESISTANCE, GROWTH AND DEVELOPMENT OF ANIMALS | 2019 |
|
RU2776671C2 |
| REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
| SOLUTION THAT HAVE ANTIPROLIFERATIVE AND ANTIMETASTATIC PROPERTIES FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2678769C2 |
| METHOD FOR COMBINED USE OF INTRANASALLY ADMINISTERED INSULIN AND ORALLY ADMINISTERED METFORMIN FOR RECOVERY OF METABOLIC AND HORMONAL PARAMETERS IN TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME | 2023 |
|
RU2824275C1 |
| CLATHRATE COMPLEX OF ARABINOGALACTAN OR ARABIC GUM WITH 20-HYDROXYECDYSONES, METHOD FOR PRODUCING IT (VERSIONS), PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT | 2013 |
|
RU2572334C2 |
| MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
| COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| METHOD OF IMPROVEMENT OF LIVER FUNCTION | 2013 |
|
RU2653478C2 |
